Navigation Links
New Study: Lp(a) Joins LDL as Heart Disease Risk Factor
Date:1/19/2010

BIRMINGHAM, Ala., Jan. 19 /PRNewswire/ -- LDL isn't the only "bad boy" when it comes to cholesterol. According to a new study, a lipoprotein in the bloodstream called Lp(a) — pronounced "LP little A" — can be labeled "bad cholesterol." The landmark study Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease recently published in the New England Journal Of Medicine provides the strongest evidence to date that Lp(a) can cause heart disease.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20091228/LA30526)

Michael Cobble, M.D., is chief medical officer of Atherotech Inc., developer of the VAP (Vertical Auto Profile) Cholesterol Test that includes Lp(a) as part of its standard panel at no additional cost. Cobble said that while LDL, non-HDL and apoB remain the most dangerous and reliable indicators of heart disease risk, Lp(a) is now a strong additive predictor of risk. All four tests are provided at no extra cost in the VAP lipid panel.

"This study will lead to changes in how physicians approach cholesterol testing and treatment because it demonstrates a growing need for expanded lipid profiling," said Cobble. "This was a well-designed study built on a foundation of several other studies showing a strong association between Lp(a) and heart disease. It gives us conclusive evidence that there is a link between increasing levels of Lp(a) and increasing risk of coronary artery disease, and it indicates that we can identify this added risk."

Cobble said the findings also help to partially explain why the standard cholesterol test fails to detect up to half the people at risk for coronary disease, a
'/>"/>

SOURCE Atherotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Study: Era of Rapid Growth in Biomedical Research Over
2. Penn study: Transforming nanowires into nano-tools using cation exchange reactions
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Attorney Wayne Keown Joins Preti Flaherty's Portland, ME Office
5. New Director of Bioanalytical Services Joins Toxikon
6. The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors
7. Dennis Winger Joins Nektar Therapeutics Board of Directors
8. Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer
9. Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner
10. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
11. Richard T. Crowder Joins Neogens Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... A new look at “big glass” ... trends will highlight technical sessions at SPIE Photomask ... its 33rd year, the three-day event is the industry’s ... suppliers, approximately 100 technical presentations and numerous networking lunches ... for optics and photonics , the meeting will be ...
(Date:6/18/2013)... million electric cars could be on roads across North America ... research by the United States Department of Energy, Los Alamos ... Chen is part of a team led by the Los ... the expensive platinum catalysts in fuel cells. , "One of ... vehicles is the cost of the units. The pure platinum ...
(Date:6/18/2013)... June 18, 2013 The Regulatory ... of two new offices in Asia—one in Singapore and ... serve as RAPS’ Pan-Asia office , serving the ... more focused on audiences within China. , The announcement ... partnership with five Singapore government agencies to develop and ...
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
Breaking Biology Technology:‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... OAKS, Calif., Dec. 11 Ceres, Inc. announced today,that ... under its,Blade Energy Crops label. The highly anticipated launch ... specifically as raw materials,for biofuels and biopower. The company ... The company reported ...
... 11 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... Directors, unexpectedly passed away on Wednesday. Dr. Waltz had been ... At the time of his death, Dr. Waltz served on ... , "The sudden loss of our ...
... CARY, N.C., Dec. 11 Cornerstone Therapeutics Inc. ... company focused on developing and commercializing prescription medications ... the status of its integration activities following the ... Inc. and Cornerstone BioPharma Holdings, Inc. on October ...
Cached Biology Technology:First Seed Sales of Dedicated Energy Crops Begin 2First Seed Sales of Dedicated Energy Crops Begin 3Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz 2Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 2Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 3Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 4Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 5
(Date:6/18/2013)... very large "dead zone" in the Gulf of Mexico ... Chesapeake Bay this year, based on several NOAA-supported forecast ... Louisiana State University, and the Louisiana Universities Marine ... hypoxic "dead" zone will be between 7,286 and 8,561 ... largest recorded. That would range from an area the ...
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
(Date:6/18/2013)... Molecular Pathology is proud to announce it will join ... on July 1, 2013. The FASEB Board approved AMP,s ... The 26 constituent societies of FASEB represent more than ... advancement of research and education in biological and biomedical ... now than ever," said Jennifer L. Hunt, MD, MEd, ...
Breaking Biology News(10 mins):NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... 1, 2011 JERUSALEM, Israel EUREKA the ... supported by 40 member states and mobilizing more than ... today announced the launch of "E!nnoVest", its new ... This web-based instrument allows investors to identify highly-qualified and ...
... DALLAS June 1, 2011 A drug already ... a therapy for a common form of dementia, UT ... acid (SAHA) holds promise as a first-generation drug for ... a progressive, inherited neurodegenerative disease for which there is ...
... Plant Biologists (ASPB) has named the recipients of its 2011 ... program assists promising undergraduate students so they can conduct meaningful ... a key element of the program, and a solid mentoring ... work with a mentor who is an ASPB member. ...
Cached Biology News:Cancer drug holds promise as first treatment for common, inherited dementia 2ASPB awards 15 summer undergraduate research fellowships 2ASPB awards 15 summer undergraduate research fellowships 3ASPB awards 15 summer undergraduate research fellowships 4
... antibody development to targets including proteins and ... and cancer-specific surface antigens. A&Gs service ... completed in approximately 40 days (duration may ... antigens). Phase I: Immunization, test bleed ...
... ZMD.368. Immunogen: Synthetic peptide derived ... human WNT2B/WNT13 protein. Specificity: Specific ... and rat WNT2B/WNT13 proteins. Recognizes both ... Reactivity: Mouse Human Rat (positive controls: ...
... Synthetic peptide derived from the N-terminal ... 17 open reading frame 37 (C17orf37 protein) ... C35 protein. On Western blots it identifies ... Reactivity: Human (positive control: full-length human ...
...
Biology Products: